The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Characterization of a novel aquaretic agent, OPC‐31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist
Open accessAbstract
OPC‐31260, a benzazepine derivative, has been studied for its ability to antagonize the binding of arginine vasopressin (AVP) to receptors in rat liver (V 1) and kidney (V 2) plasma membranes, for antagonism of the antidiuretic action of AVP in alcohol‐anaesthetized rats and for diuretic action in conscious normal rats. OPC‐31260 caused a competitive displacement of [3 H]‐AVP binding to both V 1 and V 2 receptors with IC 50 values of 1.2 ± 0.2 × 10−6 m and 1.4 ± 0.2 × 10−8 m, respectively. OPC‐31260 at doses of 10 to 100 μg kg−1, i.v., inhibited the antidiuretic action of exogenously administered AVP in water‐loaded, alcohol‐anaesthetized rats in a dose‐dependent manner. OPC‐31260 did not exert an antidiuretic activity suggesting that it is not a partial V 2 receptor agonist. After oral administration at doses of 1 to 30 mg kg−1 in normal conscious rats, OPC‐31260 dose‐dependently increased urine flow and decreased urine osmolality. The diuretic action of OPC‐31260 was characterized as aquaresis, the mode of diuretic action being different from previously known diuretic agents such as furosemide, hydrochlorothiazide and spironolactone. The results indicate that OPC‐31260 is a selective V 2 receptor antagonist and behaves as an aquaretic agent. OPC‐31260 will be a useful tool in studying the physiological role of AVP and in the treatment of various conditions characterized by water retention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
Scatchard, G. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb27297.x · Cited by 19,778
A Multiple Comparison Procedure for Comparing Several Treatments with a Control
Dunnett, C. W. (1955) · Journal of the American Statistical Association · doi:10.1080/01621459.1955.10501294 · Cited by 6,094
MICHELL, R. H., KIRK, C. J., & BILLAH, M. M. (1979) · Biochemical Society Transactions · doi:10.1042/bst0070861 · Cited by 435
OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist
Yamamura, Y., Ogawa, H., Chihara, T., Kondo, K., Onogawa, T., Nakamura, S., Mori, T., Tominaga, M., & Yabuuchi, Y. (1991) · Science · doi:10.1126/science.1850553 · Cited by 271
Self-citationPharmacology and clinical perspectives of vasopressin antagonists.
László, F. A., László, F., & De Wied, D. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06661-x · Cited by 213
Discovery, development, and some uses of vasopressin and oxytocin antagonists.
Manning, M., & Sawyer, W. H. (1989) · PubMed · Cited by 150
Dicker, S. E. (1953) · The Journal of Physiology · doi:10.1113/jphysiol.1953.sp004986 · Cited by 130
Acquisition of a beta-adrenergic response by adult rat hepatocytes during primary culture.
Nakamura, T., Tomomura, A., Noda, C., Shimoji, M., & Ichihara, A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44664-3 · Cited by 117
Clark, B. J., & Silva, M. R. E. (1967) · The Journal of Physiology · doi:10.1113/jphysiol.1967.sp008266 · Cited by 105
Cited by
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423
MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296
Gerbes, A. L., Gülberg, V., Ginès, P., Decaux, G., Gross, P., Gandjini, H., & Djian, J. (2003) · Gastroenterology · doi:10.1053/gast.2003.50143 · Cited by 289
The Basic and Clinical Pharmacology of Nonpeptide Vasopressin Receptor Antagonists
Thibonnier, M., Coles, P., Thibonnier, A., & Shoham, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.175 · Cited by 146
Neuropeptides in learning and memory processes
de Wied, D. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)86050-0 · Cited by 63
Metadata
- Authors
- Yamamura, Y., Ogawa, H., Yamashita, H., Chihara, T., Miyamoto, H., Nakamura, S., Onogawa, T., Yamashita, T., Hosokawa, T., Mori, T., Tominaga, M., & Yabuuchi, Y.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1992-04
- Volume
- 105
- Issue
- 4
- Pages
- 787-791
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2057640040
- Cited by
- 345
- References
- 13
- FWCI
- 19.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization of a novel aquaretic agent, OPC‐31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. https://app.cochat.ai/papers/10.1111/j.1476-5381.1992.tb09058.x
- The paper
- Yamamura, Y., Ogawa, H., Yamashita, H., Chihara, T., Miyamoto, H., Nakamura, S., Onogawa, T., Yamashita, T., Hosokawa, T., Mori, T., Tominaga, M., & Yabuuchi, Y. (1992). Characterization of a novel aquaretic agent, OPC‐31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1992.tb09058.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.